Zinc finger MYM-type containing 1 (ZMYM1) was identified to be the m6A modification target of METTL3, and it facilitated the EMT programing and metastasis in GC through recruiting the CtBP/LSD1/CoREST complex to mediate the repression of E-cadherin promoter activity 56. The gene discussed is METTL3; the disease is gastric cancer.